Medicine
Xerava 100 mg powder for injection
Xerava 100 mg powder for injection is a prescription medicine containing Eravacycline for intravenous use, marketed by Tetraphase Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Prior to reconstitution, XERAVA should be stored at 2°C to 8°C (36°F to 46°F).
Key facts
- Active ingredient (INN)
- Eravacycline
- Brand
- Xerava
- Strength
- 100 mg
- Dosage form
- Powder for injection
- Route
- Intravenous
- Packs
- 12 cartons
- Marketing authorisation holder
- Tetraphase Pharmaceuticals
- Manufacturer
- Tetraphase Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Prior to reconstitution, XERAVA should be stored at 2°C to 8°C (36°F to 46°F).
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J01AA13 Eravacycline
- HS code (indicative)
- 3004.20Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 10 September 2018
- Identifiers
- DailyMed set ID a4b188d4-f467-470c-ad7b-25ffbdd8862aNDC 71773-100Application NDA211109
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 12 carton in 1 package / 1 vial, glass in 1 carton / 1 injection, powder, lyophilized, for solution in 1 vial, glass | 71773-100-12 | Tetraphase Pharmaceuticals | 14 September 2020 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Eravacycline
Clinical summary
Eravacycline is a tetracycline-class antibacterial indicated for the treatment of complicated intra-abdominal infections in patients 18 years of age and older, among other approved uses. It is available as powder for injection for intravenous use. MedsAcross supplies Eravacycline for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about EravacyclineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Xerava prescribing information (Tetraphase Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Xerava: European public assessment report (EPAR) · European Medicines Agency
Need Xerava 100 mg powder for injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.